What will ASCO 18 do for BMS???

Discussion in 'Bristol-Myers Squibb' started by anonymous, May 19, 2018 at 3:47 PM.

Tags: Add Tags

  1. anonymous

    anonymous Guest

    Market is up and we are down big time. We absolutely can be bought. “Oh the board the shareholders will have our back. It’s too much process”...You’re an idiot
     
  2. anonymous

    anonymous Guest

    Bottomline. Pfizer.is.not.interested.with.BMS. Get it?
     
  3. anonymous

    anonymous Guest

    Bought possibly, and then gutted.
     
  4. anonymous

    anonymous Guest

    Nobody will acquire this shit show.
     
  5. anonymous

    anonymous Guest

     
  6. anonymous

    anonymous Guest

    LOL. Glad I'm out of there. Opdivo down the S--t hole. BMS 53.16 and Merck 62.58.
    ASCO fired up Merck. Nektar stumbles. Higher some more reps maybe that will help. A more robust voice in the territory. I hate BMS verbiage.
     
  7. anonymous

    anonymous Guest

    Yes more share of voice will help us. Plus Marty’s fire drill, metric mandate leadership regression. Might as well have Lynelle again will feel the same.
     
  8. anonymous

    anonymous Guest

    You could “reach out” to someone with that information, lol. And they could “cascade” that information.
     
  9. anonymous

    anonymous Guest

    Check flight codes of corporate....takeover is in play !!!
     
  10. anonymous

    anonymous Guest

    I’ll kiss your ASCO if you lick my ANGUS.
     
  11. anonymous

    anonymous Guest


    yep heard last week that we have CV F11a coming and guess what, nobody to sell it ex US......bye bye Cv